Cargando…

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy

Acquired ichthyosis (AI) is a reactive cutaneous manifestation that can be associated with malignant hematological disease, including cutaneous T-cell lymphoma (CTCL). Since it is difficult to distinguish AI from ichthyosiform mycosis fungoides, to select the treatment for CTCL with ichthyosis-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanita, Kayo, Fujimura, Taku, Sato, Yota, Hidaka, Takanori, Furudate, Sadanori, Kambayashi, Yumi, Tsukada, Akira, Hashimoto, Akira, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422724/
https://www.ncbi.nlm.nih.gov/pubmed/28512419
http://dx.doi.org/10.1159/000468981
_version_ 1783234835864616960
author Tanita, Kayo
Fujimura, Taku
Sato, Yota
Hidaka, Takanori
Furudate, Sadanori
Kambayashi, Yumi
Tsukada, Akira
Hashimoto, Akira
Aiba, Setsuya
author_facet Tanita, Kayo
Fujimura, Taku
Sato, Yota
Hidaka, Takanori
Furudate, Sadanori
Kambayashi, Yumi
Tsukada, Akira
Hashimoto, Akira
Aiba, Setsuya
author_sort Tanita, Kayo
collection PubMed
description Acquired ichthyosis (AI) is a reactive cutaneous manifestation that can be associated with malignant hematological disease, including cutaneous T-cell lymphoma (CTCL). Since it is difficult to distinguish AI from ichthyosiform mycosis fungoides, to select the treatment for CTCL with ichthyosis-like appearance and to evaluate its efficacy is sometimes challenging. In this report, we describe a case of primary cutaneous peripheral T-cell lymphoma not otherwise specified presenting AI successfully treated with oral bexarotene. In the present case, the administration of oral bexarotene was not only effective for lymphoma cells infiltrating ulcers and nodules, but it also eliminated AI.
format Online
Article
Text
id pubmed-5422724
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-54227242017-05-16 Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy Tanita, Kayo Fujimura, Taku Sato, Yota Hidaka, Takanori Furudate, Sadanori Kambayashi, Yumi Tsukada, Akira Hashimoto, Akira Aiba, Setsuya Case Rep Oncol Case Report Acquired ichthyosis (AI) is a reactive cutaneous manifestation that can be associated with malignant hematological disease, including cutaneous T-cell lymphoma (CTCL). Since it is difficult to distinguish AI from ichthyosiform mycosis fungoides, to select the treatment for CTCL with ichthyosis-like appearance and to evaluate its efficacy is sometimes challenging. In this report, we describe a case of primary cutaneous peripheral T-cell lymphoma not otherwise specified presenting AI successfully treated with oral bexarotene. In the present case, the administration of oral bexarotene was not only effective for lymphoma cells infiltrating ulcers and nodules, but it also eliminated AI. S. Karger AG 2017-04-06 /pmc/articles/PMC5422724/ /pubmed/28512419 http://dx.doi.org/10.1159/000468981 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Tanita, Kayo
Fujimura, Taku
Sato, Yota
Hidaka, Takanori
Furudate, Sadanori
Kambayashi, Yumi
Tsukada, Akira
Hashimoto, Akira
Aiba, Setsuya
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
title Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
title_full Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
title_fullStr Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
title_full_unstemmed Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
title_short Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
title_sort successful treatment of primary cutaneous peripheral t-cell lymphoma presenting acquired ichthyosis with oral bexarotene monotherapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422724/
https://www.ncbi.nlm.nih.gov/pubmed/28512419
http://dx.doi.org/10.1159/000468981
work_keys_str_mv AT tanitakayo successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT fujimurataku successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT satoyota successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT hidakatakanori successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT furudatesadanori successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT kambayashiyumi successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT tsukadaakira successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT hashimotoakira successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy
AT aibasetsuya successfultreatmentofprimarycutaneousperipheraltcelllymphomapresentingacquiredichthyosiswithoralbexarotenemonotherapy